CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Alcon phacoemulsification equipment +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02910362
NCT02910362N/ACompleted

Intra-surgical Evaluation of CATS Tonometer Prism and AMO Versus Alcon Phacoemulsification Machines

Intuor Technologies, Inc.·interventional·Posted Sep 22, 2016·Updated Oct 11, 2018

In Brief

A clinical study evaluating Alcon phacoemulsification equipment and AMO phacoemulsification equipment for Cataract Surgery. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This study will measure the dynamic real-time intraocular pressure (IOP) in the anterior chamber during standard phacoemulsification surgery. What is known: * Fluidics control is determined to be one of the primary drivers of physician decision making in choosing phacoemulsification equipment. * Active pressure system fluidic control has a perceived and possibly real (based upon recent literature) improvement in intra-cameral IOP stability and reduced pressure fluctuations. * Improved fluidics can allow for reduced dynamic IOP fluctuations, in-the-bag positioned phaco tip, and intra-cameral fluid flow all of which will likely improve corneal health post-operatively.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 22, 2016
Enrollment StartSep 1, 2016
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.8 years ago

Interventions

Alcon phacoemulsification equipmentdevice

cataract surgery with Alcon phacoemulsification equipment.

AMO phacoemulsification equipmentdevice

cataract surgery with AMO phacoemulsification equipment.